关节疼痛及其他关节疼痛;风湿性关节炎的挑战
1Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
The Lancet. Rheumatology
|January 22, 2024
概括
风湿性关节炎的疼痛可以持续,尽管炎症治疗. 新的方法专注于大脑机制和神经心理干预,以管理除了抑制炎症之外的疼痛.
科学领域:
- 神经科学是一个神经科学.
- 类风湿病学 类风湿病学
- 疼痛管理 疼痛管理
背景情况:
- 风湿性关节炎 (RA) 经常导致持续的疼痛,即使有抗炎治疗.
- 疼痛在RA涉及复杂的炎症和非炎症途径影响感官处理.
- 了解神经系统的作用对于有效的疼痛管理至关重要.
研究的目的:
- 为了探索类风湿性关节炎的多面性质.
- 研究神经成像在理解疼痛机制中的作用.
- 突出除了抑制炎症之外的互补治疗策略.
主要方法:
- 审查有关RA疼痛治疗点的新兴数据.
- 分析与疼痛感知有关的神经成像发现.
- 考虑用于疼痛调节的神经心理干预措施.
主要成果:
- 疼痛缓解的大小可能因炎症级联中的药理目标而异.
- 神经成像揭示了对疼痛体验的显著感官,情感和认知贡献.
- 脊上疼痛调节机制提供了新的治疗途径.
结论:
- 关节炎疼痛管理需要解决炎症和非炎症因素.
- 神经成像技术有助于我们更好地理解疼痛的中央处理过程.
- 神经心理学干预措施通过调节大脑活动和减少痛苦来补充药理疗法的承诺.
相关概念视频
Autoimmune Disorders
442
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
442
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Inflammatory Bowel Disease II: Crohn's Disease
248
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
248
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


